![Mark Sumeray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Sumeray
Directeur/Bestuurslid bij
Metys Pharmaceuticals AG
Profiel
Mark Sumeray is currently a Director at Metys Pharmaceuticals AG.
Previously, he worked as the Chief Medical Officer at Aegerion Pharmaceuticals, Inc. from 2011 to 2016 and at Amryt Pharma Holdings Ltd. from 2016 to 2022.
Dr. Sumeray received his undergraduate and doctorate degrees from University College London.
Actieve functies van Mark Sumeray
| Bedrijven | Functie | Begin |
|---|---|---|
Metys Pharmaceuticals AG
 Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark Sumeray
| Bedrijven | Functie | Einde |
|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Hoofd Techniek/Wetenschap/O&O | 27-06-2022 |
| AEGERION PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 28-01-2016 |
Opleiding van Mark Sumeray
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
